
Cardinal Health (CAH) Stock Forecast & Price Target
Cardinal Health (CAH) Analyst Ratings
Bulls say
Cardinal Health is forecasted to continue its growth trajectory due to its strong positioning in the pharmaceutical industry and increasing demand for specialty drugs. With a focus on sustainability and its leading distribution and technology services, the company is expected to outperform its competitors. Additionally, Cardinal Health's solid financial standing sets it up for continued success and potential for further expansion and innovation in the future.
Bears say
Cardinal Health is facing potential regulatory hurdles and risks in its Nuclear & Precision Health Solutions segment, as well as challenges in implementing automation and increasing specialty drug penetration. However, it has a strong distribution platform and is expanding its services and collaborations to mitigate potential impacts from changes in reimbursement and fulfillment models. The company is also returning capital to shareholders and has a strong financial position, but its future growth will depend heavily on its ability to execute its turnaround plan and successfully spin off its GMPD business.
This aggregate rating is based on analysts' research of Cardinal Health and is not a guaranteed prediction by Public.com or investment advice.
Cardinal Health (CAH) Analyst Forecast & Price Prediction
Start investing in Cardinal Health (CAH)
Order type
Buy in
Order amount
Est. shares
0 shares